- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-07-0005982

Maponus Pharmaceuticals Private Limited
About Maponus Pharmaceuticals Private Limited
Data last updated:
Maponus Pharmaceuticals Private Limited is a private limited company based in Hooghly, West Bengal, India. It operates in the chemical elements and compounds doped segment of the chemicals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24296WB2020PTC239122.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹24.15 Lakh. It is led by directors including Goutam Kumar Das and Raj Kumar Seth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Raj Kumar Seth P.O. – Kharua Vill. – Rohia (Khatal) P.S. – Dhaniakhali, Hooghly, West Bengal, India – 712308.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.69 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹11.67 Lakh (net margin -45.4%) and EBITDA of -₹10.6 Lakh (EBITDA margin -41.3%). Revenue has grown at a compounded annual rate (CAGR) of 233% over three years.
Maponus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-07-0005982). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Maponus Pharmaceuticals
Contact details
Maponus Pharmaceuticals Private Limited's registered office is in Hooghly, West Bengal.
- Registered AddressC/O Raj Kumar Seth P.O. – Kharua Vill. – Rohia (Khatal) P.S. – Dhaniakhali, Hooghly, West Bengal, India – 712308
- IndustryChemicals, Chemical Elements And Compounds Doped, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maponus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maponus Pharmaceuticals Private Limited, buy the company report.
Financials of Maponus Pharmaceuticals Private Limited
FY 2024 filings availableMaponus Pharmaceuticals Private Limited reported revenue of ₹25.69 Lakh (down 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 32% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 233%. EBITDA fell 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹10.6 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹11.67 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -41.3% | |||
| Net Profit Margin | -45.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Maponus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maponus Pharmaceuticals Private Limited
Maponus Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goutam Kumar Das | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Raj Kumar Seth Also directs: Ostrich Agrotech Private Limited | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Durga Pada De | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Maponus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maponus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maponus Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maponus Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Durga Pada De was appointed as Director on 24 Aug 2020.
Frequently asked questions
Maponus Pharmaceuticals is an active private limited company based in Hooghly, West Bengal, India. The company works in chemical elements and compounds doped, within the chemicals industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U24296WB2020PTC239122.
Maponus Pharmaceuticals has 3 current directors:
- Goutam Kumar Das - Director
- Raj Kumar Seth - Director
- Durga Pada De - Director
The latest financial statements of Maponus Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Maponus Pharmaceuticals is U24296WB2020PTC239122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maponus Pharmaceuticals was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
Durga Pada De was appointed as Director on 24 Aug 2020. Goutam Kumar Das was appointed as Director on 24 Aug 2020. Raj Kumar Seth was appointed as Director on 24 Aug 2020.
Yes, Maponus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-07-0005982).
The registered office of Maponus Pharmaceuticals is at CO Raj Kumar Seth P.O. – Kharua Vill. – Rohia Khatal P.S. – Dhaniakhali, Hooghly, West Bengal, India – 712308.
Maponus Pharmaceuticals operates in the chemicals industry, in the chemical elements and compounds doped segment.
The compliance status of Maponus Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.

